Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 22.65M | $215.0M | 8.92% | +1.51M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 15.83M | $150.0M | 6.23% | -- | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 15.04M | $143.0M | 5.92% | +697.0K | 2026-03-31 |
| STATE STREET CORP | 12.21M | $116.0M | 4.81% | +1.14M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11.24M | $107.0M | 4.43% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.14M | $106.0M | 4.38% | -- | 2026-03-31 |
| TCG Crossover Management, LLC | 11.02M | $104.0M | 4.34% | -- | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 8.91M | $84.0M | 3.51% | +1.50M | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 7.43M | $70.0M | 2.93% | +4.27M | 2026-03-31 |
| Vestal Point Capital, LP | 7.03M | $66.0M | 2.77% | +4.78M | 2026-03-31 |
